Nevertheless, the more active allele of SULT1A1 has been associated with better survival outcome in breast cancer patients treated with tamoxifen [49], possibly because the SULT1A1-mediated biotransformation of 4-hydroxytamoxifen potentiates the efficacy of tamoxifen therapy [35]. The gene discussed is SULT1A1; the disease is breast cancer.